Superior overall survival (OS) and disease-free survival (DFS) predictions for patients with glioblastoma multiforme (GBM) using Cellworks Singula: myCare-022-03

Manmeet Ahluwalia

Superior overall survival (OS) and disease-free survival (DFS) predictions for patients with glioblastoma multiforme (GBM) using Cellworks Singula: myCare-022-03

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Clinical Oncology
Volume	39
State	Published - Jan 1 2021

Access to Document

ViewcontentFinal published version, 20.4 KBLicense: Unspecified

Cite this

@article{273c279aba4e445cb3b2f2f8f13cd94c,

title = "Superior overall survival (OS) and disease-free survival (DFS) predictions for patients with glioblastoma multiforme (GBM) using Cellworks Singula: myCare-022-03",

author = "Manmeet Ahluwalia",

note = "Journal of Clinical Oncology (2021) 39(15_suppl):2017-2017",

year = "2021",

month = jan,

day = "1",

language = "American English",

volume = "39",

journal = "Journal of Clinical Oncology",

}

TY - JOUR

T1 - Superior overall survival (OS) and disease-free survival (DFS) predictions for patients with glioblastoma multiforme (GBM) using Cellworks Singula: myCare-022-03

AU - Ahluwalia, Manmeet

N1 - Journal of Clinical Oncology (2021) 39(15_suppl):2017-2017

PY - 2021/1/1

Y1 - 2021/1/1

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/4163

M3 - Article

VL - 39

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

Superior overall survival (OS) and disease-free survival (DFS) predictions for patients with glioblastoma multiforme (GBM) using Cellworks Singula: myCare-022-03

Access to Document

Other files and links

Cite this